Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients-Reference-Cited by-同舟云学术

Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients

Published:2020-06-30 Issue:11 Volume:60 Page:1432-1440
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Provenzano Robert¹,Tumlin James²,Zabaneh Raja³,Chou James⁴,Hemmerich Stefan⁴,Neff Thomas B.⁴,Yu K.‐H. Peony⁴

Affiliation:

1. Department of Medicine Wayne State University Detroit Michigan USA

2. Southeast Renal Research Institute Chattanooga Tennessee USA

3. Northwest Louisiana Nephrology Research Shreveport Louisiana USA

4. FibroGen, Inc. San Francisco California USA

Funder

FibroGen

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1648

Reference33 articles.

1. US Center of Disease Control.National Chronic Kidney Disease Fact Sheet. Center for Disease Control and Prevention Website.https://www.cdc.gov/diabetes/pubs/pdf/kidney_factsheet.pdf. Published 2017. Accessed February 21 2020.

2. Prevalence of Anemia in Chronic Kidney Disease in the United States

3. The clinical and economic burden of anemia;Smith RE;Am J Manag Care,2010

4. Anemia of chronic kidney disease: Treat it, but not too aggressively

5. Anaemia management and mortality risk in chronic kidney disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming;Inflammopharmacology;2023-05-02

2. Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study;Clinical Pharmacology in Drug Development;2023-05

3. Efficacy and Safety of Roxadustat in Chinese Hemodialysis Patients: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-03-23

4. Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefined;Clinical Kidney Journal;2023-03-01

5. Hypoxia-Inducible Factor–Prolyl Hydroxyl Domain Inhibitors: From Theoretical Superiority to Clinical Noninferiority Compared with Current ESAs?;Journal of the American Society of Nephrology;2022-11